Q4 2025 Holdings
Filed 2026-02-17 | 38 holdings | $87.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $11.8M | 40,000 | 13.5% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $6.3M | 800,000 | 7.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.9M | 100,000 | 6.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.1M | 360,000 | 5.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.3M | 160,000 | 4.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.8M | 750,000 | 4.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $3.6M | 400,000 | 4.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.8M | 36,000 | 3.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $2.7M | 36,000 | 3.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.7M | 5,500 | 3.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.3M | 300,000 | 2.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.3M | 50,000 | 2.6% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $2.2M | 70,000 | 2.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.1M | 100,000 | 2.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $2.1M | 270,000 | 2.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.0M | 24,000 | 2.2% |
| Apogee Enterprises Inc(APOG) | COM | 037598109 | $1.9M | 25,000 | 2.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.8M | 1,320,000 | 2.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.7M | 10,000 | 2.0% |
| Corcept Therapeutics Inc(CORT)Call | COM | 218352102 | $1.5M | 44,000 | 1.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $1.5M | 240,000 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.4M | 58,000 | 1.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.4M | 50,000 | 1.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.3M | 160,000 | 1.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.3M | 50,000 | 1.4% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $1.2M | 70,000 | 1.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $1.2M | 50,000 | 1.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 5,000 | 1.2% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.1M | 30,000 | 1.2% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $1.0M | 880,000 | 1.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $993.5K | 88,000 | 1.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $989.0K | 24,000 | 1.1% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $845.6K | 20,000 | 1.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $840.0K | 80,000 | 1.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $816.6K | 30,000 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $762.6K | 30,000 | 0.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $750.0K | 30,000 | 0.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $348.5K | 12,000 | 0.4% |